RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

It often mimics the common cold, but RSV can quickly turn into bronchiolitis and pneumonia. “The older you get, the milder ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

Sanofi and partner AstraZeneca have received approval from the U.S. Food and Drug Administration for a manufacturing line for ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

With the flu season imminent, new COVID-19 and influenza vaccines are available. What’s new with the vaccines and when should ...